Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm

Faisal Aziz, Helena Kuivaniemi

Research output: Contribution to journalReview articlepeer-review

69 Scopus citations


Abdominal aortic aneurysm (AAA) is a significant health problem in the United States, with approximately 30,000 repair operations annually. Treatment of AAA is associated with more than 150,000 hospital admissions per year. The development of AAA is characterized by destruction of the elastic media of the aortic wall. A large body of evidence suggests that a group of enzymes called matrix metalloproteinases (MMPs) plays a significant role in the destruction of extracellular matrix in the aortic wall. MMP inhibition has, therefore, been viewed as an alternative pharmacotherapeutic approach to slow down the development and progression of small AAAs, thus reducing the need for surgical intervention.

Original languageEnglish (US)
Pages (from-to)392-401
Number of pages10
JournalAnnals of Vascular Surgery
Issue number3
StatePublished - May 2007

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Role of Matrix Metalloproteinase Inhibitors in Preventing Abdominal Aortic Aneurysm'. Together they form a unique fingerprint.

Cite this